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The exquisite selectivity and catalytic activity of enzymes have
been shaped by the effects of positive and negative selection
pressure during the course of evolution. In contrast, enzyme
variants engineered by using in vitro screening techniques to
accept novel substrates typically display a higher degree of cata-
lytic promiscuity and lower total turnover in comparison with their
natural counterparts. Using bacterial display and multiparameter
flow cytometry, we have developed a novel methodology for
emulating positive and negative selective pressure in vitro for the
isolation of enzyme variants with reactivity for desired novel
substrates, while simultaneously excluding those with reactivity
toward undesired substrates. Screening of a large library of ran-
dom mutants of the Escherichia coli endopeptidase OmpT led to the
isolation of an enzyme variant, 1.3.19, that cleaved an Ala–Arg
peptide bond instead of the Arg–Arg bond preferred by the WT
enzyme. Variant 1.3.19 exhibited greater than three million-fold
selectivity (-Ala–Arg--Arg–Arg-) and a catalytic efficiency for Ala–
Arg cleavage that is the same as that displayed by the parent for
the preferred substrate, Arg–Arg. A single amino acid Ser223Arg
substitution was shown to recapitulate completely the unique
catalytic properties of the 1.3.19 variant. These results can be
explained by proposing that this mutation acts to ‘‘swap’’ the P1
Arg side chain normally found in WT substrate peptides with the
223Arg side chain in the S1 subsite of OmpT.
engineering  flow cytometry
The reprogramming of enzyme catalytic activity and selectiv-ity is a central issue in protein biochemistry and biotechnol-
ogy. Numerous structure-guided and directed evolution strate-
gies have been used in search of enzyme variants that exhibit high
catalytic rates with poor or inactive substrates of the parental
enzyme (1–19). As impressive as these successes have been, the
engineering of enzymes that exhibit turnover rates and selectiv-
ities with new substrates comparable to their natural counter-
parts has proven quite a challenge, especially when considering
those enzymes for which a genetic selection strategy is not
possible.
In particular, enzymes engineered through laboratory evolu-
tion involving in vitro catalytic assays have often been found
lacking, either with respect to turnover rates or selectivity,
relative to catalyst–substrate pairs isolated from natural sources.
As a typical example, an extensive directed evolution program
led to the isolation of Escherichia coli -glucuronidase variants
with significant -galactosidase (10) or xylanosidase (11) activ-
ities, but nonetheless even the best clones exhibited kcatKm
values 1,000 times lower than those of naturally occurring
enzymes such as the E. coli -galactosidase or the Thermoanaer-
obacterium saccharolyticum -xylosidase.
This trend appears to be general. In a recent comprehensive
study, Aaron et al. (12) demonstrated that the evolution of higher
activity toward poor substrates did not impair the parental
catalytic activity, and, therefore, the evolved enzymes exhibited
greater promiscuity. Enzymes evolved for higher substrate en-
antioselectivity often exhibit lower specific activities toward their
new substrates relative to their respective parental enzymes
(13–15). Similarly, the evolution of highly active variants of
aspartate aminotransferases capable of accepting branched or
aromatic amino acid substrates was accompanied by a relaxation
of the substrate selectivity (16, 17).
In nature, the evolution of enzymes occurs as the result of
positive selective pressure for turnover of physiological sub-
strates, combined with simultaneous negative selective pressure
to eliminate completely, or at least drastically suppress, delete-
rious activities. It follows that the engineering of enzymes
exhibiting high catalytic activity and substrate selectivity for a
particular desired substrate should be similarly accomplished by
implementing selection and counterselection assay schemes in
the laboratory. The recent directed evolution of novel tRNA
synthetases and recombinases by capitalizing on in vivo selec-
tions support this expectation (18–19). Unfortunately, many
desired enzyme activities are not amenable to in vivo selection
strategies because cellular growth cannot be linked to the
enzyme activity being sought. Consequently, laboratory-directed
evolution approaches for the isolation of highly selective en-
zymes must rely on in vitro catalytic assays whereby the activity
toward selection and counterselection substrates is determined
sequentially for each library member (9–11, 13, 14). The suc-
cessful implementation of the latter approach hinges on satis-
fying the following requirements. First, assays that afford the
proper dynamic range must be designed because mutant proteins
are likely to exhibit drastically different kcat and Km values for the
various selection and counterselection substrates. Second, the
isolation of rare, high-activity clones requires the screening of
large libraries by assaying each clone toward multiple substrates,
thus necessitating the availability of suitable high-throughput
methods.
With these considerations in mind, we have extended our
previous approach (20) and developed a new two-pronged
strategy in which catalytic activities over a wide dynamic range
for both a selection substrate and one or more counterselection
substrates are quantified simultaneously at the single-cell level,
enabling the rapid screening of mutant libraries. This approach
relies on fluorescent substrates of different colors that label the
surface of E. coli cells upon cleavage by a surface-anchored
enzyme (20). Enzymes can be displayed on the surface of
Gram-negative bacteria by established techniques (21, 22), and
thus, access to the fluorescent substrate is assured. The net result
is that the cell f luorescence profile accurately reflects the
catalytic activity and selectivity of the surface-displayed enzyme.
Multiparameter flow cytometry is then used to isolate clones
This paper was submitted directly (Track II) to the PNAS office.
Abbreviation: BODIPY, 4,4-difluoro-5,7-dimethyl-4-bora-3a,4a-diaza-s-indacene-3-propi-
onic acid.
‡N.V. and J.G. contributed equally to this work.
¶To whom correspondence may be addressed at: Department of Chemical Engineering,
University of Texas, Austin, TX 78712. E-mail: gg@che.utexas.edu.
To whom correspondence may be addressed at: Department of Chemistry and Biochem-
istry, University of Texas, Campus Mail Code A5300, Austin, TX 78712. E-mail:
biverson@mail.utexas.edu.
© 2005 by The National Academy of Sciences of the USA
www.pnas.orgcgidoi10.1073pnas.0500063102 PNAS  May 10, 2005  vol. 102  no. 19  6855–6860
BI
O
CH
EM
IS
TR
Y
expressing enzymes having a desired fluorescence profile from
large libraries.
The E. coli endoprotease OmpT and its Omptin homologues
play important roles in pathogenicity, are of significance in
protein manufacturing, and have been exploited for biotechnol-
ogy applications (23, 24). OmpT has a strong preference for
cleavage between two basic residues (Lys and, especially, Arg) in
the P1 and P1
 positions of the substrate (25–27). We sought to
isolate OmpT variants that exhibit (i) hydrolysis of a substrate
that is cleaved poorly by the WT enzyme and (ii) a low rate of
cleavage of dibasic sequences (preferred by the WT enzyme),
thus conferring (iii) a high selectivity for the new cleavage over
the one preferred by the parental enzyme (Fig. 1A), while
maintaining (iv) a very high level of catalytic activity.
Materials and Methods
Substrate Synthesis. The peptides 1a, Ac-CARVGKGRGR-NH2,
and 2a, Glu-EEGGRRIGRGGK-NH2, were synthesized at the
University of Texas peptide synthesis facility. Tetramethylrho-
damine-5-iodoacetamide (TMRIA), 5-carboxytetramethylrho-
damine, succinimidyl ester (5-TAMRA, SE), and BODIPY-
FL-SE were purchased from Molecular Probes. The peptides 3,
WCARVGKGRGR-NH2, and 4, WEEGGRRIGRGGK-NH2
(95% purity), were purchased from Cell Essentials (Boston).
For the synthesis of the FRET substrate 1, a 50-l solution of
peptide 1a (5.4 mg, 4.9 mol) in water was added to 100 l of
1 M Na2CO3 and 50 l of 0.5M NaHCO3. A solution of 50 l of
TMRIA (4.0 mg, 4.8 mol) in dimethylformamide was added to
the reaction mixture and stirred at room temperature for 1h. The
reaction mixture was quenched with 5 ml of 0.1% trif luoroacetic
acid in water, and the product was purified by FPLC, using a
10–30% acetonitrile gradient. The purified product (2.6 mg,
35% yield) was freeze-dried and dissolved in 500 l of water, and
its identity was confirmed by both 1H-NMR and electrospray
ionization (ESI)-MS. For the conjugation of BODIPY, a 90-l
Fig. 1. Flow-cytometric schemes and assays described in this study. (A) Two-color discrimination and selection by using the FRET and electrostatic capture
substrates. (B) Library sort gate R3, used to isolate positive clones displaying high FL-1 (from the hydrolysis of 1) and low FL-2 (lack of hydrolysis of 2) fluorescence.
(C) Flow-cytometric discrimination of E. coliUT5600 (ompT) transformed with pML19 (expressing WT OmpT), pML1.2.19, and pML1.3.19 by using FRET substrate
1. Briefly, the cells were washed and resuspended in 1% sucrose and labeled with 50 nM (final concentration) of the AR-FRET substrate 1. A 20-l aliquot of the
labeling reaction was transferred to 0.5 ml of 1% sucrose and analyzed on the flow cytometer.
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solution of the purified product (1.9 mg, 1.2 mol) in water was
mixed with a 90-l solution of BODIPY-FL-SE (0.5 mg, 1.3
mol) in dimethylformamide. Twenty-five microliters of 1 M
DMAP (25 mol) was added to the reaction mixture and stirred
at room temperature for 1 h. The reaction mixture was quenched
with 5 ml of 0.1% trif luoroacetic acid in water and purified by
FPLC with a 10–30% acetonitrile gradient. The purified product
(0.7 mg, 32% yield) was freeze-dried, dissolved in 500 l of
water, and quantified by UV. The product identity was con-
firmed by both 1H-NMR and ESI-MS.
The electrostatic capture substrate 2was synthesized exactly as
described above for BODIPY conjugation, except that
5-TAMRA, SE was used instead of BODIPY-FL-SE.
Flow-Cytometric Analysis. E. coli UT5600 [F ara-14 leuB6 secA6
lacY1 proC14 tsx-67 (ompT-fepC)266 entA403 trpE38 rfbD1
rpsL109(StrR) xyl-5 mtl-1 thi-1] was transformed with pML19 (28)
encoding WT OmpT under the control of its native promoter.
Overnight cultures of UT5600 and UT5600pML19 were resus-
pended in 1% sucrose, diluted to 0.01 OD600, labeled for 10 min
with 50 nM 1 in 1% sucrose, diluted into 1 ml of 1% sucrose, and
analyzed by using a Becton Dickinson FACSort.
Molecular Biology Methods. A library of random mutants was
constructed by error-prone PCR using the Diversify mutagenesis
kit (Clontech). The PCR product, pAMP1 vector DNA (Life
Technologies), annealing buffer, and 2 units of uracil DNA
glycosylase in a total volume of 20 l were incubated for 40 min
at 37°C, followed by 1 h at 4°C. The reaction mixture was used
to electroporate electrocompetent E. coli DH10B [F mcrA
(mrr-hsdRMS-mcrBC) 80lacZM15 lacX74 recA1 endA1
araD139 (ara, leu)7697 galU galK -rpsL nupG] cells, and the
entire library was plated on selective media. The clones were
pooled and frozen at 80°C in aliquots.
OmpT mutants in which Ser-223 was substituted with Arg,
Gly, Leu, Lys, Phe, or Trp were constructed by using the
QuikChange site-directed mutagenesis kit (Stratagene) with
pML19 as the template and appropriate overlapping primer
pairs.
Library Screening. Transformants were grown at 37°C in LB
media, harvested after 16 h, washed once with 1% sucrose, and
resuspended in 1% sucrose. A 50-l aliquot of the cell suspen-
sion in sucrose was added to 949 l of 1% sucrose and labeled
by using 1 l of each 1 and 2 (final concentration 100 nM). A
20-l aliquot of this labeling reaction was diluted into 1%
sucrose and analyzed on the flow cytometer. Library sorting was
performed on a Becton Dickinson FACSCalibur instrument,
using gates set based on forward scatterside scatter and FL1
FL2 values. A total of 3  106 cells were sorted in 29 min, and
1,050 clones were isolated and then resorted. The collected
solution was filtered, and the filters were placed on agar plates
containing 200 gml ampicillin. After 14 h, 99 colonies that
grew were individually inoculated into 1 ml of LB media
containing 200 gml ampicillin. Individual colonies were
screened by using either substrate 1 or 2 on the flow cytometer
and the exact protocol described above.
Enzyme Purification and Kinetic Analysis. Proteins were isolated as
previously described, with minor modifications (20), to a final
purity 90% as determined by SDSPAGE. For kinetic analy-
ses, 10–20 nM of the purified enzymes were incubated with 20
M to 1 mM of the appropriate substrate in 0.1 M Tris10 mM
EDTA (pH 8.0) at room temperature (25°C), and the reaction
was monitored by HPLC on a Phenomenex C18 reverse-phase
column, using the following gradient: 5% AcN95% H2O for 1
min, increasing to 95% AcN5% H2O over a period of 29 min
and returning to 5% AcN95% H2O over 5 min. The product
concentration was determined by using the integration areas at
280 nm, and the apparent rates were fitted to a Michaelis–
Menten kinetic equation by nonlinear regression. The cleavage
products were determined by LC-MS (ESI) on a Magic 2002
instrument (Micron Bioresources, Auburn, CA).
Results
Two-Color Flow Cytometric Screening Strategy. Electrostatic inter-
actions between the negatively charged bacterial surface (29)
and substrates 1 and 2 (Fig. 2) were exploited to capture the
fluorescent and positively charged products of the enzymatic
cleavage reaction on the surface of the bacteria. The selection
substrate 1 is a FRET peptide with a net 3 charge, the
minimum charge required for cell-surface capture (30). Sub-
strate 1 is electrostatically adsorbed on the cell surface but upon
cleavage, the N-terminal moiety consisting of Ac-NH2-CA
bound to the tetramethylrhodamine dye is released from the cell,
resulting in accumulation of the C-terminal peptide, which is
positively charged and contains the BODIPY (4,4-dif luoro-5,7-
dimethyl-4-bora-3a,4a-diaza-s-indacene-3-propionic acid) f lu-
orophore. Substrate 1was used as the selection substrate because
it accumulates on the cell surface before cleavage, resulting in a
high effective molarity, which in turn, enables the detection of
even very weak catalytic activity. The counterselection substrate
2 was a zwitterionic peptide containing a single fluorophore and
at least three positive charges on one side of the scissile bond
(Arg–Arg), as well as an equal number of negatively charged
groups on the other (Fig. 1A). The intact substrate has no net
charge, but enzymatic cleavage generates a positively charged
moiety carrying the fluorescent dye that is deposited on the cell
surface. Upon incubation with 2, ompT cells exhibited a
10-fold higher fluorescence relative to the E. coli ompT
deletion strain UT5600 (data not shown). The combination of a
surface-bound selection FRET substrate 1 and zwitterionic
counterselection substrate 2 that is free in solution afforded the
proper dynamic range required for isolation of highly active and
selective enzymes.
Library Screening. C5 is an OmpT variant exhibiting a 60-fold
increase in activity toward cleavage at a nonpreferred Arg–Val
site (20). However, as is typically the case for engineered
enzymes, C5 exhibits relaxed overall specificity and is not
selective for the cleavage of Arg–Val sites. For example, the C5
variant also cleaved peptide substrates at Ala–Arg sequences
with a catalytic efficiency even higher than that of theWTOmpT
(Table 1), as well as other sequences (20). The gene encoding C5
downstream from the ompT promoter was subjected to random
mutagenesis by error-prone PCR (30), and a library of1 106
transformants was generated. DNA sequencing of 10 randomly
selected clones revealed a mutation rate of 1.1% nucleotides per
gene. The E. coli library was incubated in a solution of 1%wtvol
sucrose (to maintain proper osmotic balance) together with 100
nM of the electrostatic capture substrate 2 and the FRET
Fig. 2. Substrates used for the detection of catalytic activity and for the
kinetic analysis.
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substrate 1 for 10 min. Bacterial cells displaying increased
BODIPY fluorescence (green, emission at 530 nm, FL-1) and
reduced tetramethylrhodamine fluorescence (red, emission at
560 nm, FL-2) corresponding to high activity with substrate 1 and
reduced activity with the counterselection peptide 2, respec-
tively, were isolated (Fig. 1B). A total of 1,050 clones were
obtained, and after resorting, 99 clones were isolated, grown
individually in microtiter well plates. Two clones, 1.3.19 and
1.2.19, were selected for further study because they both exhib-
ited high green fluorescence (Fig. 1C) and reduced red fluores-
cence consistent with the sorting criteria used for their isolation.
Sequencing determined that 1.2.19 contained Asp208Gly and
Asp214Val mutations, whereas 1.3.19 contained Ser17Gly and
Ser223Argmutations in addition to those found in C5, the parent
enzyme used in this study.
The 1.2.19 and 1.3.19 proteins were extracted in n-octyl--
glucoside and purified (25). Kinetic analysis of the purified
OmpT 1.2.19 and 1.3.19 (Table 1) proteins by using unlabeled
peptide substrates 3 and 4 (Fig. 2) revealed that the selection
yielded the anticipated outcome, namely, highly active enzymes
that are specific for the hydrolysis of 3 (in particular, cleavage of
the Ala–Arg peptide bond) but impaired in their ability to attack
Arg–Arg. It is interesting to note that although cleavage between
any two amino acids in the linker region between the fluoro-
phore and the quencher would lead to increased FL-1 fluores-
cence, the two best variants 1.2.19 and 1.3.19 hydrolyzed sub-
strate 3 between Ala and Arg. In addition, 1.3.19 did not exhibit
the secondary cleavage activities displayed by its parental en-
zyme C5. Importantly, compared with the WT OmpT, 1.3.19
displayed a3 106 reversal in selectivity (Table 1) for Ala–Arg
over Arg–Arg cleavage, but its enzymatic activity for cleavage of
3 (kcatKM  1.5  105 s1M1) was nearly identical to that of
theWTOmpT for its own preferred substrate 4 (kcatKM 1.7
105 s1M1). The isolation of both 1.2.19 and 1.3.19 suggests that
such highly selective, highly active catalysts, as opposed to
enzymes with expanded specificity or low catalytic activity
toward new substrates, can be easily isolated by multiparameter,
quantitative screening of large libraries.
Site-Specific OmpT Mutants. With the exception of the Ser17Gly
mutation in 1.3.19, the other three amino acid substitutions in
the two isolated clones resulted in mutations that involved
charged residues. Examination of the recently reported structure
of OmpT (31) pointed to a significant role for Ser223Arg and
Asp208Gly in modulating peptide substrate specificity, because
these residues are located deep in the active-site cleft.
Ser223Arg and Asp208Gly were constructed by using site-
directed mutagenesis and purified as described above. LC-MS of
the substrate cleavage products revealed that the OmpT
Ser223Arg and Asp208Gly enzymes cleaved 3 only between Ala
and Arg. Neither variant produced the secondary Lys–Gly
cleavage that is generated by the WT OmpT (kcatKM  4  103
s1M1) as well as the C5 enzyme. In addition, the single amino
acid variants recapitulated the high selectivities and catalytic
activities displayed by 1.2.19 and 1.3.19, respectively (Table 1).
In particular, Ser223Arg completely abolished the ability of
OmpT to cleave Arg–Arg sites (no cleavage of 4 could be
detected after 24 h incubation) yet cleaved 3 at Ala–Arg with
a kcatKM value slightly higher than that of 1.3.19. In addition, the
Ser223Arg mutant did not cleave substrate 5 (Fig. 2), further
underscoring its specificity for Ala–Arg. The effect of the
Ser223Arg mutation appeared to be unique, because insertion of
Trp, Lys, Leu, Gly, or Phe at the 223 position by using site-
directed mutagenesis resulted in variants that did not exhibit
cleavage of substrate 1 comparable to even WT OmpT when
monitored by FACS (Fig. 5).
Discussion
We have developed a high-throughput strategy for the quanti-
tative screening of enzyme libraries by using simultaneous
selection and counterselection criteria. The methodology pre-
sented depends on (i) the display of enzyme libraries on the
surface of microorganisms, (ii) retention of fluorescent reaction
products on the cell surface, and (iii) multicolor flow cytometry
for the isolation of clones that can selectively turn over one or
more substrates. The combination of electrostatic and FRET
substrates afforded the proper dynamic range required to screen
a wide array of enzymatic activities, an important consideration
when screening large enzyme libraries.
Display of enzymes on the surface of microorganisms such as
E. coli or yeast can be accomplished in a variety of ways (32, 33).
In this manner, the enzyme can react with exogenous synthetic
substrates, circumventing the substrate transport limitations
associated with methods that use intracellularly expressed en-
zymes. In our approach, the enzymatic reaction generates flu-
orescent products that become associated with the cell surface,
resulting in a fluorescence profile representative of the catalytic
selectivity of the displayed enzyme. Although we have capital-
ized on electrostatic interactions for product capture, a number
of other methods for cell-surface modification (34, 35) may be
exploited for the capture of reaction products. In addition to the
directed evolution of protease selectivity reported here, we
believe that our methodology can be extended to other enzymes
including various hydrolases and ligases.
We screened an OmpT error-prone library to select for
variants that preferred a new peptide substrate at the expense of
activity with the WT preferred substrate. After three rounds of
sorting, we obtained 10 clones that displayed the desired spec-
ificity profile, the best of which were 1.2.19 and 1.3.19. Although
the targeted error-rate for the library was 1.1% (11 bases), both
1.2.19 (Asp208Gly and Asp214Val) and 1.3.19 (Ser17Gly and
Ser223Arg) had just two extra mutations each, relative to C5
Table 1. Kinetic parameters for the cleavage of substrate 3 and substrate 4 by OmpT, C5, and the four mutants
Enzyme
™A™R™* ™R™R™†
Specificity
™AR™™RR™kcat, s1 KM, M
kcatKM,
s1M1 kcat, s1 KM, M
kcatKM,
s1M1
OmpT 3.1 	 0.5  102 16 	 5 2.2 	 0.9  103 8.8 	 0.7 55 	 9 1.7 	 0.4  105 1.3  102
C5 1.7 	 0.5  102 1.5 	 0.6 1.4 	 0.8  104 0.7 	 0.1 2.2 	 0.4 3 	 1.0  105 3.6  102
1.2.19 1.7 	 0.3 9 	 1 2.1 	 0.6  105 0.4 	 0.1 260 	 90 2 	 1  103 1.0  102
1.3.19 2.2 	 0.4 15 	 3 1.5 	 0.1  105 4.9 	 0.6  104 160 	 30 3 	 1 4.7  104
S223R 2.3 	 0.1 9 	 2 2.6 	 0.8  105 n.d. n.d. n.d. 1.8  105
D208G 1.6 	 0.1 7.3 	 0.8 2.4 	 0.7  105 0.3 	 0.1 240 	 100 2 	 1  103 1.4  102
Reactions were carried out at room temperature. n.d., not detected.
*Substrate sequence: WCARVGKGRGR-NH2.
†Substrate sequence: WEEGGRRIGRGGK-NH2.
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(20), the starting enzyme construct. A detailed kinetic analysis
of the isolated enzymes proved both to be consistent with the
flow-cytometric screening criteria. In other words, both of these
enzymes have altered, as opposed to relaxed, substrate specificity
yet maintain a native level of catalytic activity.
Examination of the crystal structure of OmpT (31) indicated
that the Asp208Gly mutation in 1.2.19 and the Ser223Arg in
1.3.19 might be the primary determinants of the altered speci-
ficity profiles of these enzymes. Construction of these single
point mutants of OmpT confirmed that Asp208Gly was similar
to 1.2.19 in terms of specificity and overall activity. Unexpect-
edly, Ser223Arg was more specific than 1.3.19, especially in
eliminating cross-reactivity with the WT preferred Arg–Arg-
containing substrate 4. Importantly, the Ser223Arg variant was
as active with substrate 3 as WT OmpT with its preferred
substrate 4. Thus, for the Ser223Arg single-mutation variant of
OmpT, altered specificity has not come at the cost of overall
catalytic activity.
It is worth mentioning that although OmpT is a trypsin-like
protease (36), the Ser223Arg substitution conferred specificity
more analogous to that of chymotrypsin. The effect of this single
amino acid substitution should be contrasted with the conversion
of trypsin to chymotrypsin that required a monumental effort
and hinged on major reorganization of the substrate-binding
surface (37, 38).
A crystal structure of OmpT has been published (31), but no
structural information is available for OmpT containing a bound
substrate or substrate analog. Nevertheless, inspection of the
OmpT structure leads to a reasonable prediction for the location
of an unusually deep S1 binding pocket (Fig. 3), with the Ser-223
residue located near the bottom of this pocket. Consistent with
our proposed role of the 223 residue in substrate recognition, a
recent molecular dynamics calculation using WT OmpT and an
Fig. 4. Arg side-chain swapping. The Arg occupying the P1 subsite is accom-
modated by Ser-223 in S1. In the 1.3.19 mutant, the Ser223Arg only allows
occupancy by Ala in the P1 site of the substrate.
Fig. 5. Flow-cytometric analysis of the OmpTSer223 mutants. Briefly, the
cells were washed and resuspended in 1% sucrose and labeled with 50 nM
(final concentration) of the AR-FRET substrate 1. A 20-l aliquot of the
labeling reaction was transferred to 0.5 ml of 1% sucrose and analyzed on the
flow cytometer. Dark blue, S223W; orange, S223L; light blue, S223F; dark
green, S223K; pink, S223G; red, OmpT; light green, S223R.
Fig. 3. The crystal structure of OmpT. (A) The electrostatic potential surface of OmpT (31) generated by using WEBLAB VIEWERLITE (Accelrys, San Diego). (B) The
side chains corresponding to Asp-208 and Ser-223 are shown in addition to the proposed catalytic residues, Asp-83, Asp-85, and Asp-210 and His-212.
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Arg–Arg-containing substrate placed the P1 Arg side chain
deep in the same S1 pocket proposed here and adjacent to
Ser-223 (39).
The high activity seen with Ser223Arg likely reflects a simple
swapping of an important residue from the peptide substrate to
the enzyme active site. Because enzymes evolve to be catalyti-
cally active in the presence of substrate, it makes sense that some
functional groups attached to the substrate could modulate
active site structure and thus catalytic activity to a significant
degree. This is the basis of Koshland’s induced fit theory of
enzyme catalysis (40) in which substrate binding is required to
convert an enzyme active site into the proper catalytic arrange-
ment. A logical interpretation of our data is that the Ser223Arg
substitution replaces important induced fit interactions of the P1
Arg side chain of a bound substrate (Fig. 4) with the 223Arg side
chain that is now attached to the enzyme in S1. A significant
structural role for the restored guanidium group would explain
why the Ser223Arg variant has WT levels of catalytic activity.
Interestingly, the decreased rate of catalysis seen for WT OmpT
reacting with the nonpreferred substrate 3 (that lacks the P1 Arg
residue) is primarily a reflection of a substantially lower kcat
value, possibly consistent with the induced fit hypothesis that a
guanidium group in the P1-S1 site is important for high levels of
catalytic activity. To investigate this hypothesis, we constructed
five OmpTSer223 mutants, OmpTSer223Phe, OmpTSer223Gly,
OmpTSer223Lys, OmpTSer223Leu, and OmpTSer223Trp.
These five mutants were designed to test whether the guanidium
group is essential in the P1-S1 site for high catalytic activity or if
steric (Phe, Trp), hydrophobic (Leu), or positively charged (Lys)
residues can help achieve the same goal. Flow-cytometric anal-
ysis (Fig. 5) demonstrates that none of these mutants had even
a WT level of activity with substrate 1, confirming the need for
a guanidium group.
Swapping important residues at protein–protein and pro-
tease–substrate interfaces has been accomplished by rational
design (41, 42). For 1.3.19, this apparent swapping occurred as
a result of combined selection and counterselection. In that
regard, the isolation of the OmpT Ser223Arg variant supports
the notion that residue swapping at protein–peptide interfaces
represents a facile mechanism for substrate diversification as the
result of evolutionary pressure without any preconceived notions
regarding the protein structure.
Impressive as our findings with OmpT Ser223Arg might be, in
general, the engineering of large changes in substrate specificity
is expected to require multiple amino acid substitutions leading
to extensive remodeling of the active site. Thus, whereas in this
case the Ser223Arg mutant could have been identified by
screening a small library using manual techniques, the evolution
of mutants of OmpT or other enzymes that can react selectively
with nonnative substrates will likely require the screening of very
large libraries. Therefore, a high overall assay throughput
dynamic range and the ability to place selection and counters-
election evolutionary pressure on an enzyme to be evolved are
key to the isolation of rare, change-of-function clones. Selection
and counterselection assays can be carried out in a tiered
approach, wherein the library is screened first for one substrate
and then the active clones are screened for activity with the
counterselection substrate. As shown here, however, selection
and counterselection can also be applied simultaneously, anal-
ogous to living systems. Simultaneous screening by FACS ac-
commodates high throughput and is particularly attractive for
carrying out evolutionary experiments using three or more
substrates, as required to explore ‘‘substrate space.’’
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